Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension (Q45816538)
Jump to navigation
Jump to search
scientific article published on 4 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension |
scientific article published on 4 July 2013 |
Statements
1 reference
Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension (English)
1 reference
Makoto Araie
1 reference
Hidenobu Tanihara
1 reference
Toshihiro Inoue
1 reference
Tetsuya Yamamoto
1 reference
Yasuaki Kuwayama
1 reference
Haruki Abe
1 reference
K-115 Clinical Study Group
1 reference
4 July 2013
1 reference
156
1 reference
4
1 reference
731-736
1 reference